Zeruesenay Desta

12PUBLICATIONS
74CO-AUTHORS
PharmacogenomicsBehavioural epidemiologyCharacterisation of biological macromoleculesEpidemiological modellingReaction engineering (excl. nuclear reactions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 08, 2026
How Drug-Drug Interaction Studies Inform Drug Labeling: A Survey of US Food and Drug Administration-Approved New Molecular Entities from 1998 to 2022.

|Mar 07, 2026
Pharmacokinetic Drug-Drug Interaction Potential of Oral Anticancer Drugs.

Fatimah Alhurayri, Islam R Younis, Shadia I Jalal

|Jan 20, 2026
Efavirenz and CYP2C9 Genetic Polymorphisms Reduce CYP2C9 Activity in Healthy Participants.

Jason D Kim, Ingrid F Metzger, Jessica Bo Li Lu

|Dec 26, 2025
Genotype-Specific Safety and Pharmacokinetics of Cannabidiol in Healthy Volunteers.

Jumar Etkins, Gerald C So, Jessica Bo Li Lu

|Sep 24, 2025
A Population Pharmacokinetic Approach to Understand the Effect of Efavirenz on CYP3A Activity in Healthy Volunteers Using Midazolam as a Probe.

Kimberly S Collins, Blessed W Aruldhas, Ingrid F Metzger

|Sep 20, 2025
Clinical Pharmacogenetics Implementation Consortium Guideline for NAT2 Genotype and Hydralazine Therapy.

Michael T Eadon, David W Hein, Michael A Andersen

Pageof 2

Frequent Collaborators

5 joint publications

Michael T Eadon

4 joint publications

Gerald C So

3 joint publications

Debora L Gisch

2 joint publications

Teri E Klein